M

MDxHealth SA
NASDAQ:MDXH

Watchlist Manager
MDxHealth SA
NASDAQ:MDXH
Watchlist
Price: 1.94 USD 3.74% Market Closed
Market Cap: 96m USD
Have any thoughts about
MDxHealth SA?
Write Note

MDxHealth SA
Selling, General & Administrative

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

MDxHealth SA
Selling, General & Administrative Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Selling, General & Administrative CAGR 3Y CAGR 5Y CAGR 10Y
M
MDxHealth SA
NASDAQ:MDXH
Selling, General & Administrative
-$92m
CAGR 3-Years
-45%
CAGR 5-Years
-19%
CAGR 10-Years
-15%
Galapagos NV
AEX:GLPG
Selling, General & Administrative
-€187.4m
CAGR 3-Years
3%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
Oxurion NV
XBRU:OXUR
Selling, General & Administrative
-€3.8m
CAGR 3-Years
24%
CAGR 5-Years
21%
CAGR 10-Years
N/A
Celyad Oncology SA
XBRU:CYAD
Selling, General & Administrative
-€4.1m
CAGR 3-Years
23%
CAGR 5-Years
15%
CAGR 10-Years
N/A
No Stocks Found

MDxHealth SA
Glance View

Market Cap
96m USD
Industry
Biotechnology

MDxHealth SA engages in the development and commercialization of molecular diagnostic products for personalized cancer treatment. The company is headquartered in Herstal, Liege. The company went IPO on 2006-06-26. The Company’s tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, as well as prediction of response to a specific therapy. Its tests include ConfirmMDx for Prostate Cancer, SelectMDx for Prostate Cancer, PredictMDx for Glioblastoma and AssureMDx for Bladder Cancer. The firm's corporate operations are based in Herstal, Belgium, as well as Irvine, the United States, and its laboratory operations are based in Nijmegen, the Netherlands, as well as Irvine, the United States.

MDXH Intrinsic Value
9.14 USD
Undervaluation 79%
Intrinsic Value
Price
M

See Also

What is MDxHealth SA's Selling, General & Administrative?
Selling, General & Administrative
-92m USD

Based on the financial report for Jun 30, 2024, MDxHealth SA's Selling, General & Administrative amounts to -92m USD.

What is MDxHealth SA's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
-15%

Over the last year, the Selling, General & Administrative growth was -22%. The average annual Selling, General & Administrative growth rates for MDxHealth SA have been -45% over the past three years , -19% over the past five years , and -15% over the past ten years .

Back to Top